Ahead of its closely watched R&D day, Sanofi has again expanded a pact with one of its key COVID-19 collaborators Translate Bio Inc. to develop messenger RNA (mRNA) vaccines across all infectious disease areas, making a hefty upfront payment to close the deal.
The two companies have been partners since 2018 when they signed a deal to develop mRNA vaccines for up to...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
